CA057-003
An Exploratory Phase 1b/2a Multicenter, Open-Label, Novel-Novel Combination Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of CC-92480 (BMS-986348) in Novel Therapeutic Combinations in Participants With Relapsed or Refractory Multiple Myeloma
Near Add Your Location
Sorting 11 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Not currently accepting
- Show Principal Investigator
Dana-Farber Cancer Institute
Boston, MA
- Accepting patients
- Show Principal Investigator
Memorial Sloan Kettering Nassau
Uniondale, NY
- Not currently accepting
- Show Principal Investigator
Memorial Sloan Kettering Bergen
Montvale, NJ
- Not currently accepting
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack Meridian Health
Hackensack, NJ
- Accepting patients
- Show Principal Investigator
Memorial Sloan Kettering Basking Ridge
Basking Ridge, NJ
- Not currently accepting
- Show Principal Investigator
Memorial Sloan Kettering Westchester
West Harrison, NY
- Not currently accepting
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
Memorial Sloan Kettering Commack
Commack, NY
- Not currently accepting
- Show Principal Investigator
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.